The COVID numbers continue to get worse.
Shown here, an illustration combining Atrium Health, @CaroMontHealth and @NovantHealth hospitals in the Charlotte area. We, along with healthcare system across the country, ask you to please get vaccinated. https://t.co/sFYESAYBpH
There are between 50 and 100 documented subtypes of sarcoma. This makes an already rare cancer even more challenging for drug development and research. Post a picture holding a sign with your subtype so we can spread awareness about the many different subtypes. #CureSarcoma
Today is Leiomyosarcoma Awareness Day. Leiomyosarcoma is a rare type of cancer that affects smooth muscle tissue. Learn about pathologic findings, patterns of growth and common imaging features of retroperitoneal leiomyosarcoma in @RadioGraphics. https://t.co/ePHZtdnQt7
@Sarcoma_UK Did you do your own survey to determine that 75% people don’t know what sarcoma is? Or did you find that statistic elsewhere? Interesting but not shocking either!
2. People with ASS1 negative tumors were the most likely to respond. "The activity is tantalizing," Dr. Bob Benjamin said. 3 people with #leiomyosarcoma got a complete response. A phase 3 trial is in development. #ASCO21#sarcoma
1. @bvantine1's phase 2 trial of ADI-PEG20 found it can be safely & effectively given with a dose of 600mg/m2 #gemcitabine + 60mg/m2 #docetaxel to patients with soft-tissue #sarcoma. #leiomyosarcoma#ASCO21 https://t.co/W3teulhzIX https://t.co/DGUEkdCUGL
I'm so glad the paywall has been removed from this important study by @Thalcin@ProfDMThomas & colleagues on global #disparities in #sarcoma. https://t.co/HYKWFNGqIP
The #CTOS2021 meeting will be Nov 10-13 in Vancouver. It will be virtual, but @ctosociety hopes to have an in-person component. @WinanvanHoudt is program chair, with co-chairs: Liz Demicco, @ylc2001 & @ManuPalmerini. Abstract submission is open: https://t.co/DURjwioHE1 #sarcoma
The @SarcomaAlliance is upping its grants from $500 to $1,000 to reimburse people who get a second opinion from a #sarcoma specialist. https://t.co/0aYVNaupJZ
Broad, @DanaFarber, and @count_me_in launch research projects in two rare cancers, with focus on optimizing patient engagement; efforts aim to reveal rare cancer's genetic roots, mechanisms of drug resistance, and potential new treatment strategies. https://t.co/8XyVBV6Hj1
This paper calls for more involvement of patients to understand side effects from #immunotherapy. #Sarcoma patients: Please report any problems! You're not bothering doctors & nurses. They need to know what's up.
At #CTOS2020 we’re excited to introduce LIVE multidisciplinary discussions of clinical cases in GIST, Soft Tissue Sarcomas, and Bone #Sarcomas in our “Meet-the Experts” sessions. Counting down the weeks until annual!